Delivery Order SPE2DR25D1202-SPE2DR26F72FX
Award Date 11/17/25
Potential Completion Date 11/18/25
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,006.15 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalant medication used in the treatment of chronic obstructive pulmonary disease. The contract, awarded November 10, 2025, with an ultimate completion date of November 12, 2025, utilizes firm fixed pricing under a non-set-aside, competitively awarded arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,132.72 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract, awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating open and competitive procurement. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 (a combination inhalation medication for chronic obstructive pulmonary disease) valued at $11,953.57 on October 31, 2025, with completion targeted for November 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhaler medication used to treat chronic obstructive pulmonary disease. This competitively awarded, non-set-aside delivery order, valued at $2,067.33, was executed on September 26, 2025, with an ultimate completion date of September 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $10,252.23 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, which was competitively awarded without set-aside provisions, carries a firm fixed price structure and was finalized on November 4, 2025, with an ultimate completion date of November 5, 2025. The pharmaceutical will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a $2,086.50 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhaler medication used to treat chronic obstructive pulmonary disease. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract, valued at $10,848.83, was competitively awarded with no set-aside designation and carries a firm fixed price structure. Performance is scheduled to be completed by August 4, 2025, with the work to be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $12,545.94 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,859.04 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $32,431.82 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhaler medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents...